Skip to main content

Table 1 Clinical cure and pathogen eradication rates by treatment group

From: Efficacy of telavancin for treatment of surgical site infections

  TLV SA VAN SA TLV MRSA VAN MRSA
Clinical cure, n (%) 41 (85) 33 (70) 18 (86) 15 (71)
Pathogen eradication, n (%) 40 (83) 30 (64) 17 (81) 12 (57)